您要查找的是不是:
- Changes of DA l dopamine receptor subtype in vascular smooth muscle of old rats 老年大鼠血管平滑肌中多巴胺受体DA1亚型的改变
- D and 5-HT1F receptor subtype mRNAs were present in the DRGs. 蜜蜂毒致痛后大鼠腰段脊髓和 DRG内 5-HT;
- Objective: To detect the genetic association between chronic tic disorder( CTD) and the polymorphism in the dopamine receptor D5 gene. 目的研究慢性抽动障碍与多巴胺D5受体基因多态性是否相关联。
- Clinical treatment of PD includes dopamine replacement such as L-DOPA and D_2 dopamine receptor agonist. 目前临床仍以替代治疗为主,左旋多巴和D_2受体激动剂能改善PD症状,但不能阻制疾病发展,这使人们对PD治疗的认识由单纯替代疗法逐渐转向保护中脑DA能神经元。
- AIM To observe the distribution of 5 HT 5A receptor subtype (5 HT 5A R) in the rat nervous system. 目的 观察大鼠神经系统内 5 - HT5A受体亚型 (5 -HT5AR)的定位分布 .
- Rotigotine is a non-ergolinic dopamine receptor agonist available as a patch for once-daily use. 罗替戈汀是现有非二氢麦角碱多巴胺受体激动剂中可作为每日一次使用的辅助药物。
- This article reviews the important roles of dopamine receptor in sodium reabsorption and blood pressure. 现就多巴胺受体在调节机体血压和肾脏利钠、利尿作用中所发挥的重要作用作一综述。
- Rotigotine is a non-ergolinic dopamine receptor agonist aailable as a patch for once-daily use. 罗替戈汀是现有非二氢麦角碱多巴胺受体激动剂中可作为每日一次使用的辅助药物。
- SNI also resulted in a significant increase in the mRNA expression of 5-HT_7 receptor subtype at 1 d, then maintained at a high level to 28 d. 5-HT7 受体亚型mRNA的表达在术后 1d时即显著升高,一直维持高水平的表达至28d。
- Background Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease. 背景:有发现表明常用于治疗帕金森病的麦角洐生的多巴胺受体激动剂可增加发生瓣膜性心脏病的风险。
- Sodium ions have been shown to play an important role in the binding of antipsychotic drugs to the D2 Dopamine receptor. 钠离子在将D2多巴胺受体融入抗精神病药物合成的过程中扮演着极其重要的角色。
- Objective To investigate the role and mechanism of bombesin receptor subtype 3(BRS-3) in the proliferation and protection against injury of human brochial epithelial cells(HBECs). 目的:研究蛙皮素受体亚型-3(bombesin receptor subtype-3,BRS-3)激活对人支气管上皮细胞(hum an broch ial ep ithelial cells,HBECs)增殖的影响及对HBECs抗损伤的保护作用,并探讨其初步机制。
- AIM To study the changes and effects of metabotropic glutamate receptor subtype 2 (mGluR2) in diffuse brain injuries (DBI) coupled with secondary brain insults (SBI) in rats. 目的 研究弥漫性脑损伤 (diffusebraininjury;DBI)及其合并二次脑损伤 (secondarybraininsults;SBI)后大鼠脑皮层代谢性谷氨酸受体 2亚型 (mGluR2 )的变化及其意义 .
- Researchers found that risk takers have less of a particular type of dopamine receptor, thus they feel happier than normal people when seeking novelty. 研究者发现,冒险者的大脑中没有足够的多巴胺"接收器"来存多巴胺,因此,冒险爱好者每次追求刺激时都会尝到比一般人更大的快感。
- AIM To study the changes and effects of metabotropic glutamate receptor subtype 4 (mGluR4) after diffuse brain injuries (DBI) coupled with secondary brain insults (SBI) in rats. 目的 研究弥漫性脑损伤 (DBI)及其合并二次脑损伤 (SBI)后大鼠脑皮层代谢型谷氨酸受体亚型 4(m Glu R4)的变化及意义 .
- Both classes of drugs are dopamine receptor antagonists that work by blocking the action of naturally occurring dopamine in the brain. 两类药物都多巴胺受体拮抗剂,通过阻断大脑自然发生的多巴胺活性发挥效用。
- During both in vivo and in vitro development, CGC depend on the activity of the NMDA glutamate receptor subtype for survival and full differentiation [3]. 在体内和体外发育过程中,小脑颗粒细胞依赖于N-甲基-D-天冬氨酸(NMDA)谷氨酸盐受体亚型的活性而生存和完全分化。
- Background Ergot-deried dopamine receptor agonists, often used in the treatment of Parkinson's disease, hae been associated with an increased risk of alular heart disease. 背景:有发现表明常用于治疗帕金森病的麦角洐生的多巴胺受体激动剂可增加发生瓣膜性心脏病的风险。
- The target receptor of psychoactive substance is opioid receptor and the non-target receptor mainly includes dopamine receptor, NMDA receptor, histamine receptor, and so on. 精神活性物质作用的靶受体为阿片受体,非靶受体主要包括多巴胺受体、N-甲基-D-门冬氨酸(NMDA)受体和组胺等。
- Immunocytochemical staining technique by using specific antibody against 5-HT 1A receptor subtype (5-HT 1A R) was used to observe the distribution of 5-HT 1A R immunoreactivity in the rat nervous system. 应用免疫组织化学技术观察了大鼠神经系统内 5 -羟色胺 1A受体亚型 ( 5 -HT1 AR)免疫阳性结构的分布。